181 related articles for article (PubMed ID: 31549775)
1. Impact of different preanalytical conditions on results of lupus anticoagulant tests.
Kristoffersen AH; Hammer IJ; Vannes S; Åsberg A; Aakre KM
Int J Lab Hematol; 2019 Dec; 41(6):745-753. PubMed ID: 31549775
[TBL] [Abstract][Full Text] [Related]
2. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
4. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
Grypiotis P; Ruffatti A; Pengo V; Tonello M; Biasiolo A; Zamboni D; Cavazzana A; Todesco S
J Clin Lab Anal; 2006; 20(1):15-8. PubMed ID: 16470527
[TBL] [Abstract][Full Text] [Related]
5. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
Moore GW; Peyrafitte M; Dunois C; Amiral J
Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
[TBL] [Abstract][Full Text] [Related]
6. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
Lee Y; Gu JY; Kim HK
J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
[TBL] [Abstract][Full Text] [Related]
7. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of silica clotting time for detection of lupus anticoagulants].
Lee HR; Kim JE; Ha SH; Kim HK; Park S; Cho HI
Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
[TBL] [Abstract][Full Text] [Related]
11. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin.
Martinuzzo ME; Barrera LH; D 'adamo MA; Otaso JC; Gimenez MI; Oyhamburu J
Int J Lab Hematol; 2014 Apr; 36(2):144-50. PubMed ID: 24034808
[TBL] [Abstract][Full Text] [Related]
12. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
[TBL] [Abstract][Full Text] [Related]
13. Dry ice exposure of plasma samples influences pH and lupus anticoagulant analysis.
Odsæter IH; Lian IA; Bratberg K; Mikkelsen G
Clin Chem Lab Med; 2015 Apr; 53(5):809-13. PubMed ID: 25257161
[TBL] [Abstract][Full Text] [Related]
14. Practice and performance of lupus anticoagulant tests: A single centre experience.
Tay Za K; Jayaranee S; Shanmugam H
Malays J Pathol; 2020 Apr; 42(1):51-57. PubMed ID: 32342930
[TBL] [Abstract][Full Text] [Related]
15. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
[TBL] [Abstract][Full Text] [Related]
16. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
17. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
[TBL] [Abstract][Full Text] [Related]
18. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
Moore GW
Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
20. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
